Recordati Industria Chimica e Farmaceutica S.p.A. Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| AZN | AstraZeneca PLC | Outperform |
17
|
£121.66 | Buy/Sell | £165.99 | 34.02% | 16 | £188.60B |
| ABT | Abbott Laboratories | Outperform |
9
|
$104.87 | Buy/Sell | $118.92 | 20.63% | 7 | $182.44B |
| PFE | Pfizer | Outperform |
2
|
$28.92 | Buy/Sell | $32.87 | 5.46% | 6 | $163.88B |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.14k | Buy/Sell | ¥4.74k | 8.75% | 0 | ¥6.49T |
| ARGX | argenx | Outperform |
4
|
344.90€ | Buy/Sell | 531.81€ | 26.53% | 10 | 20.50€B |
| GMAB | Genmab A/S | Outperform |
16
|
kr2.03k | Buy/Sell | kr2.71k | 30.31% | 14 | kr130.86B |
| VTRS | Viatris Inc | Hold |
8
|
$11.02 | Buy/Sell | $11.73 | 8.89% | 5 | $13.32B |
| IPN | Ipsen | Outperform |
17
|
121.40€ | Buy/Sell | 127.95€ | -1.15% | 0 | 9.88€B |
| CHDN | Churchill Downs | Buy |
16
|
$134.93 | Buy/Sell | $143.67 | 7.46% | 2 | $10.17B |
| ZEAL | Zealand Pharma A/S | Outperform |
8
|
kr618.50 | Buy/Sell | kr357.00 | 31.77% | 2 | kr38.52B |
| HIK | Hikma Pharmaceuticals PLC | Outperform |
18
|
£19.83 | Buy/Sell | £28.11 | 47.30% | 9 | £4.42B |
| ORNBV | Orion Oyj | Hold |
14
|
37.71€ | Buy/Sell | 42.52€ | 11.38% | 3 | 5.12€B |
| ALK B | ALK-Abelló A/S | Outperform |
13
|
kr155.90 | Buy/Sell | kr109.25 | 5.84% | 3 | kr33.91B |
| ALRM | Alarm.com Holdings | Outperform |
16
|
$69.66 | Buy/Sell | $67.13 | 20.59% | 7 | $3.45B |
| VIRP | Virbac | Outperform |
18
|
359.50€ | Buy/Sell | 348.34€ | 4.31% | 5 | 2.98€B |
| MOR | MorphoSys | Hold |
6
|
69.05€ | Buy/Sell | 28.78€ | -1.52% | 3 | 2.52€B |
| CORT | Corcept Therapeutics | Buy |
16
|
$27.54 | Buy/Sell | $35.67 | 45.24% | 4 | $2.55B |
| BHC | Bausch Health Companies | Hold |
15
|
$7.07 | Buy/Sell | $9.50 | 34.37% | 5 | $2.55B |
| INDV | Indivior PLC | Buy |
14
|
£13.52 | Buy/Sell | £28.89 | 128.77% | 4 | £1.95B |
| PENN | PENN Entertainment | Outperform |
13
|
$15.94 | Buy/Sell | $29.89 | 31.74% | 1 | $2.29B |
| ALM | Almirall | Outperform |
16
|
9.51€ | Buy/Sell | 11.39€ | 15.67% | 3 | 1.94€B |
| EVT | Evotec | Outperform |
14
|
10.27€ | Buy/Sell | 37.33€ | 65.53% | 4 | 1.73€B |
| COPN | Cosmo Pharmaceuticals N.V. | Buy |
12
|
CHF73.50 | Buy/Sell | CHF76.55 | 27.29% | 0 | CHF1.14B |
| FAE | Faes Farma | Hold |
18
|
3.60€ | Buy/Sell | 3.90€ | 1.39% | 0 | 1.09€B |
| MERC | Mercer International | Hold |
14
|
$10.35 | Buy/Sell | $8.63 | 3.86% | 4 | $722.06M |
| PHM | Pharma Mar | Outperform |
13
|
36.24€ | Buy/Sell | 50.20€ | 32.45% | 1 | 536.95€M |
| BSLN | Basilea Pharmaceutica | Outperform |
6
|
CHF44.30 | Buy/Sell | CHF65.63 | 48.98% | 0 | CHF529.94M |
| SFA | Sopharma AD | Buy |
14
|
лв5.98 | Buy/Sell | лв6.96 | 19.40% | 0 | лв997.04M |
| XERS | Xeris Biopharma Holdings | Buy |
6
|
$2.02 | Buy/Sell | $4.60 | 147.52% | 1 | $260.93M |
| DBV | DBV Technologies | Outperform |
5
|
1.30€ | Buy/Sell | 4.07€ | 207.69% | 1 | 115.65€M |
| MOLN | Molecular Partners | Outperform |
4
|
CHF3.42 | Buy/Sell | CHF9.50 | 173.39% | 1 | CHF110.77M |